The global oncology information system (OIS) market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of cancer cases and rising awareness about cancer treatment. The OIS market has been segmented into patient information system, treatment planning system, oncology information system (OIS), by application and by region. North America is expected to dominate the global OIS market with a share of over 40%. This can be attributed to the presence of major players in this region such as GE Healthcare, Philips Healthcare and Siemens Healthcare.
Some Of The Growth Factors Of This Market:
- The OIS market is expected to reach $3,890 million by 2022.
- Increasing number of cancer cases and rising awareness about the benefits of OIS are the major factors driving the growth of this market.
- Lack of skilled professionals and high cost associated with implementation are some factors that may hamper the growth of this market.
- North America is expected to dominate this market during forecast period.
Industry Growth Insights published a new data on “Oncology Information System (OIS) Market”. The research report is titled “Oncology Information System (OIS) Market research by Types (Patient Information System, Treatment Planning System, Oncology Information System (OIS), By Applications (Radiation Oncology, Medical Oncology, Surgical Oncology), By Players/Companies Accuray Incorporated, Bogardus Medical Systems, Cerner Corporation, CureMD Corporation, Elekta, Flatiron Health, McKesson, RaySearch Laboratories, Varian Medical Systems, Bizmatics, Oncology Information System (OIS”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Oncology Information System (OIS) Market Research Report
By Type
Patient Information System, Treatment Planning System, Oncology Information System (OIS
By Application
Radiation Oncology, Medical Oncology, Surgical Oncology
By Companies
Accuray Incorporated, Bogardus Medical Systems, Cerner Corporation, CureMD Corporation, Elekta, Flatiron Health, McKesson, RaySearch Laboratories, Varian Medical Systems, Bizmatics, Oncology Information System (OIS
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Oncology Information System (OIS) Market Report Segments:
The global Oncology Information System (OIS) market is segmented on the basis of:
Types
Patient Information System, Treatment Planning System, Oncology Information System (OIS
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Radiation Oncology, Medical Oncology, Surgical Oncology
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Accuray Incorporated
- Bogardus Medical Systems
- Cerner Corporation
- CureMD Corporation
- Elekta
- Flatiron Health
- McKesson
- RaySearch Laboratories
- Varian Medical Systems
- Bizmatics
- Oncology Information System (OIS
Highlights of The Oncology Information System (OIS) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Patient Information System
- Treatment Planning System
- Oncology Information System (OIS
- By Application:
- Radiation Oncology
- Medical Oncology
- Surgical Oncology
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oncology Information System (OIS) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Oncology Information System (OIS) is a national cancer database that provides information on cancer patients and their treatments. The OIS is operated by the National Cancer Institute (NCI).
Some of the key players operating in the oncology information system (ois) market are Accuray Incorporated, Bogardus Medical Systems, Cerner Corporation, CureMD Corporation, Elekta, Flatiron Health, McKesson, RaySearch Laboratories, Varian Medical Systems, Bizmatics, Oncology Information System (OIS.
The oncology information system (ois) market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Oncology Information System (OIS) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Oncology Information System (OIS) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Oncology Information System (OIS) Market - Supply Chain
4.5. Global Oncology Information System (OIS) Market Forecast
4.5.1. Oncology Information System (OIS) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Oncology Information System (OIS) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Oncology Information System (OIS) Market Absolute $ Opportunity
5. Global Oncology Information System (OIS) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Oncology Information System (OIS) Market Size and Volume Forecast by Type
5.3.1. Patient Information System
5.3.2. Treatment Planning System
5.3.3. Oncology Information System (OIS
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Oncology Information System (OIS) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Oncology Information System (OIS) Market Size and Volume Forecast by Application
6.3.1. Radiation Oncology
6.3.2. Medical Oncology
6.3.3. Surgical Oncology
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Oncology Information System (OIS) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Oncology Information System (OIS) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Oncology Information System (OIS) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Oncology Information System (OIS) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Oncology Information System (OIS) Demand Share Forecast, 2019-2026
9. North America Oncology Information System (OIS) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Oncology Information System (OIS) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Oncology Information System (OIS) Market Size and Volume Forecast by Application
9.4.1. Radiation Oncology
9.4.2. Medical Oncology
9.4.3. Surgical Oncology
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Oncology Information System (OIS) Market Size and Volume Forecast by Type
9.7.1. Patient Information System
9.7.2. Treatment Planning System
9.7.3. Oncology Information System (OIS
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Oncology Information System (OIS) Demand Share Forecast, 2019-2026
10. Latin America Oncology Information System (OIS) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Oncology Information System (OIS) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Oncology Information System (OIS) Market Size and Volume Forecast by Application
10.4.1. Radiation Oncology
10.4.2. Medical Oncology
10.4.3. Surgical Oncology
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Oncology Information System (OIS) Market Size and Volume Forecast by Type
10.7.1. Patient Information System
10.7.2. Treatment Planning System
10.7.3. Oncology Information System (OIS
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Oncology Information System (OIS) Demand Share Forecast, 2019-2026
11. Europe Oncology Information System (OIS) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Oncology Information System (OIS) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Oncology Information System (OIS) Market Size and Volume Forecast by Application
11.4.1. Radiation Oncology
11.4.2. Medical Oncology
11.4.3. Surgical Oncology
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Oncology Information System (OIS) Market Size and Volume Forecast by Type
11.7.1. Patient Information System
11.7.2. Treatment Planning System
11.7.3. Oncology Information System (OIS
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Oncology Information System (OIS) Demand Share, 2019-2026
12. Asia Pacific Oncology Information System (OIS) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Oncology Information System (OIS) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Oncology Information System (OIS) Market Size and Volume Forecast by Application
12.4.1. Radiation Oncology
12.4.2. Medical Oncology
12.4.3. Surgical Oncology
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Oncology Information System (OIS) Market Size and Volume Forecast by Type
12.7.1. Patient Information System
12.7.2. Treatment Planning System
12.7.3. Oncology Information System (OIS
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Oncology Information System (OIS) Demand Share, 2019-2026
13. Middle East & Africa Oncology Information System (OIS) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Oncology Information System (OIS) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Oncology Information System (OIS) Market Size and Volume Forecast by Application
13.4.1. Radiation Oncology
13.4.2. Medical Oncology
13.4.3. Surgical Oncology
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Oncology Information System (OIS) Market Size and Volume Forecast by Type
13.7.1. Patient Information System
13.7.2. Treatment Planning System
13.7.3. Oncology Information System (OIS
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Oncology Information System (OIS) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Oncology Information System (OIS) Market: Market Share Analysis
14.2. Oncology Information System (OIS) Distributors and Customers
14.3. Oncology Information System (OIS) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Accuray Incorporated
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bogardus Medical Systems
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Cerner Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CureMD Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Elekta
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Flatiron Health
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. McKesson
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. RaySearch Laboratories
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Varian Medical Systems
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Bizmatics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Oncology Information System (OIS
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook